FLT3 and acute myeloid leukemia: FLT3-CAR T cells have been developed in the preclinical stage, and data from studies using FLT3mut+ AML xenograft mice have demonstrated that FLT3-CAR T cells can significantly prolong the survival of the mice [16, 17].